Avai Bio (AVAI) Non-Current Assets (2018 - 2026)

Avai Bio has disclosed Non-Current Assets across 9 years of filings, most recently posting $637469.0 for Q2 2026.

• In Q2 2026, Non-Current Assets rose 409.59% year-over-year to $637469.0; the TTM figure through Jun 2026 stood at $1.4 million (up 136.69% YoY), while the FY2026 annual figure was $483356.0, up 267.26% from the prior year.
• Non-Current Assets came in at $637469.0 for Q2 2026 at Avai Bio, up from $483356.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $637469.0 in Q2 2026 to a low of $112060.0 in Q4 2025.
• Average Non-Current Assets over 5 years is $210417.9, with a median of $146369.5 recorded in 2022.
• Year-over-year, Non-Current Assets tumbled 41.79% in 2024 and jumped 409.59% in 2026.
• Over 5 years, Non-Current Assets stood at $137710.0 in 2022, then surged by 83.86% to $253199.0 in 2023, then tumbled by 41.79% to $147379.0 in 2024, then declined by 23.96% to $112060.0 in 2025, then surged by 468.86% to $637469.0 in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $637469.0 in Q2 2026, $483356.0 in Q1 2026, and $112060.0 in Q4 2025.